GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xbrane Biopharma XBRANE.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

12.25

-3.54%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Xbrane Biopharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
RevenueSEK 152.4mSEK 198.7mSEK 238.7mSEK 57.6mSEK 11.5m
Operating income−SEK 72.1m−SEK 217.9m−SEK 310.4m−SEK 166.2m−SEK 180.6m
Net incomeSEK 127.2m−SEK 266.2m−SEK 388.2m−SEK 172.2m−SEK 191.0m
Free cash flow−SEK 390.3m−SEK 186.0m−SEK 423.4m−SEK 254.0m−SEK 297.0m
Total assetsSEK 671.6mSEK 842.4mSEK 653.5mSEK 690.5mSEK 688.4m
Shareholders' equitySEK 560.7mSEK 208.5mSEK 171.3mSEK 424.9mSEK 431.7m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.